Oral delivery of Brucella spp. recombinant protein U-Omp16 abrogates the IgE-mediated milk allergy

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 7, 2014, Pages 2015-2023

  Smaldini, Paola Lorena ^a   Ibañez, Andrés Esteban ^b   Fossati, Carlos Alberto ^a   Cassataro, Juliana ^b,c   Docena, Guillermo Horacio ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

Author keywords

IgE; Immunomodulation; Intestinal mucosa; Milk allergy; Oral adjuvant; U Omp16

Indexed keywords

CHOLERA TOXIN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 5; MILK PROTEIN; RECOMBINANT OUTER MEMBRANE PROTEIN 16; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; IMMUNOLOGICAL ADJUVANT; OUTER MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BRUCELLA ABORTUS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DRUG EFFICACY; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MILK ALLERGY; MOUSE; MOUSE MODEL; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SKIN TEST; SPLEEN CELL; SYMPTOM; TH1 CELL; TH1 TH2 BALANCE; TH2 CELL; TREATMENT DURATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; IMMUNOLOGY; MILK HYPERSENSITIVITY; ORAL DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BRUCELLA ABORTUS; IMMUNOGLOBULIN E; MALE; MICE, INBRED BALB C; MILK HYPERSENSITIVITY; MILK PROTEINS; RECOMBINANT PROTEINS; TH1 CELLS; TH2 CELLS;

EID: 84908363805     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.28845     Document Type: Article

References (33)

1. Strachan DP. Hay fever, hygiene, and household size. BMJ (Clinical Research Ed); 299:1259-60.
2. Hertzen LC. The hygiene hypothesis in the development of atopy and asthma - still a matter of controversy? QJM 1998; 91:767-71; PMID:10024940; http://dx.doi.org/10.1093/qjmed/91.11.767
3. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000; 55(Suppl 1):S2-10; PMID:10943631; http://dx.doi.org/10.1136/thorax.55.suppl-1.S2
4. Okada H, Kuhn C, Feillet H, Bach J-F. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol 2010; 160:1-9; PMID:20415844; http://dx.doi.org/10.1111/j.1365-2249.2010.04139.x
5. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 2004; 112:352-63; PMID:15196202; http://dx.doi.org/10.1111/j.1365-2567.2004.01925.x
6. Bilenki L, Gao X, Wang S, Yang J, Fan Y, Han X, Qiu H, Yang X. Dendritic cells from mycobacteria-infected mice inhibits established allergic airway inflammatory responses to ragweed via IL-10- and IL-12-secreting mechanisms. J Immunol 2010; 184:7288-96; PMID:20483754; http://dx.doi.org/10.4049/jimmunol.0902829
7. Rona RJ, Keil T, Summers C, Gislason D, Zuidmeer L, Sodergren E, Sigurdardottir ST. The prevalence of food allergy?: a meta-analysis. J Allergy Clin Immunol. 2007;120(3):638-46
8. Daser A, Meissner N, Herz U, Renz H. Role and modulation of T-cell cytokines in allergy. Curr Opin Immunol 1995; 7:762-70; PMID:8679117; http://dx.doi.org/10.1016/0952-7915(95)80045-X
9. Gieni RS, Yang X, HayGlass KT. Allergen-specific modulation of cytokine synthesis patterns and IgE responses in vivo with chemically modified allergen. J Immunol 1993; 150:302-10; PMID:7678032
10. Kitagaki K, Businga TR, Kline JN. Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice. Clin Exp Immunol 2006; 143:249-59; PMID:16412048; http://dx.doi.org/10.1111/j.1365-2249.2005.03003.x
11. Pasquevich KA, García Samartino C, Coria LM, Estein SM, Zwerdling A, Ibañez AE, Barrionuevo P, Oliveira FS, Carvalho NB, Borkowski J, et al. The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis. J Immunol 2010; 184:5200-12; PMID:20351187; http://dx.doi.org/10.4049/jimmunol.0902209
12. Ibañez AE, Smaldini P, Coria LM, Delpino MV, Pacífico LGG, Oliveira SC, Risso GS, Pasquevich KA, Fossati CA, Giambartolomei GH, et al. Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteins. PLoS One 2013; 8:e69438; PMID:23861971; http://dx.doi.org/10.1371/journal.pone.0069438
13. Boutajangout A, Goni F, Knudsen E, Schreiber F, Quartermain D, Frangione B, Chabalgoity A, Sigurdsson EM. Diminished amyloid-beta burden in Tg2576 Mice Following a Prophylactic Oral Immunization with a Salmonella-based Aβ Derivative Vaccine. J Alzheimers Dis 2009; 18:961-72; PMID:19749432
14. Moingeon P, Lombardi V, Saint-Lu N, Tourdot S, Bodo V, Mascarell L. Adjuvants and vector systems for allergy vaccines. Immunol Allergy Clin North Am 2011; 31:407-19, xii; PMID:21530828; http://dx.doi.org/10.1016/j.iac.2011.03.001
15. Nguyen CT, Hong SH, Ung TT, Verma V, Kim SY, Rhee JH, Lee SE. Intranasal immunization with a flagellin-adjuvanted peptide anticancer vaccine prevents tumor development by enhancing specific cytotoxic T lymphocyte response in a mouse model. Clin Exp Vaccine Res 2013; 2:128-34; PMID:23858404; http://dx.doi.org/10.7774/cevr.2013.2.2.128
16. Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006; 6:148-58; PMID:16491139; http://dx.doi.org/10.1038/nri1777
17. Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11(Suppl):S45-53; PMID:15812489; http://dx.doi.org/10.1038/nm1213
18. Lambrecht BN, Kool M, Willart MA, Hammad H. Mechanism of action of clinically approved adjuvants. Curr Opin Immunol 2009; 21:23-9; PMID:19246182; http://dx.doi.org/10.1016/j.coi.2009.01.004
19. Blaas SH, Stieber-Gunckel M, Falk W, Obermeier F, Rogler G. CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells. Clin Exp Immunol 2009; 155:534-40; PMID:19220839; http://dx.doi.org/10.1111/j.1365-2249.2008.03855.x
20. Beeh K-M, Kanniess F, Wagner F, Schilder C, Naudts I, Hammann-Haenni A, Willers J, Stocker H, Mueller P, Bachmann MF, et al. The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma. J Allergy Clin Immunol 2013; 131:866-74; PMID:23384679; http://dx.doi.org/10.1016/j.jaci.2012.12.1561
21. Malyala P, Chesko J, Ugozzoli M, Goodsell A, Zhou F, Vajdy M, O'Hagan DT, Singh M. The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles. J Pharm Sci 2008; 97:1155-64; PMID:17683059; http://dx.doi.org/10.1002/jps.21065
22. Uematsu S, Fujimoto K, Jang MH, Yang BG, Jung YJ, Nishiyama M, Sato S, Tsujimura T, Yamamoto M, Yokota Y, et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol 2008; 9:769-76; PMID:18516037; http://dx.doi.org/10.1038/ni.1622
23. Broide DH, Stachnick G, Castaneda D, Nayar J, Miller M, Cho JY, Roman M, Zubeldia J, Hayashi T, Raz E. Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma. J Clin Immunol 2001; 21:175-82; PMID:11403224; http://dx.doi.org/10.1023/A:1011078930363
24. Tighe H, Takabayashi K, Schwartz D, Van Nest G, Tuck S, Eiden JJ, Kagey-Sobotka A, Creticos PS, Lichtenstein LM, Spiegelberg HL, et al. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000; 106:124-34; PMID:10887315; http://dx.doi.org/10.1067/mai.2000.107927
25. Shirota H, Sano K, Kikuchi T, Tamura G, Shirato K. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J Immunol 2000; 164:5575-82; PMID:10820231; http://dx.doi.org/10.4049/jimmunol.164.11.5575
26. Teshima R, Okunuki H, Sato Y, Akiyama H, Maitani T, Sawada J. Effect of oral administration of CpG ODN-OVA on WBB6F1-W/Wv mice. Allergol Int. 2006; 55:43-8
27. Weiss R, Scheiblhofer S, Thalhamer J. Allergens are not pathogens: Why immunization against allergy differs from vaccination against infectious diseases. Hum Vaccin Immunother 2013; 10:10; PMID:24280693
28. Klimek L, Willers J, Hammann-Haenni A, Pfaar O, Stocker H, Mueller P, Renner WA, Bachmann MF. Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study. Clin Exp Allergy 2011; 41:1305-12; PMID:21672053; http://dx.doi.org/10.1111/j.1365-2222.2011.03783.x
29. Fujihashi K, Koga T, van Ginkel FW, Hagiwara Y, McGhee JR. A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants. Vaccine 2002; 20:2431-8; PMID:12057597; http://dx.doi.org/10.1016/S0264-410X(02)00155-X
30. Glueck R. Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization. Vaccine 2001; 20(Suppl 1):S42-4; PMID:11587809; http://dx.doi.org/10.1016/S0264-410X(01)00292-4
31. Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, Spyr C, Steffen R. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004; 350:896-903; PMID:14985487; http://dx.doi.org/10.1056/NEJMoa030595
32. Levine MM, Black RE, Clements ML, Lanata C, Sears S, Honda T, Young CR, Finkelstein RA. Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine. Infect Immun 1984; 43:515-22; PMID:6693169
33. Smaldini P, Curciarello R, Candreva A, Rey MA, Fossati CA, Petruccelli S, Docena GH. In vivo evidence of cross-reactivity between cow's milk and soybean proteins in a mouse model of food allergy. Int Arch Allergy Immunol 2012; 158:335-46; PMID:22472742; http://dx.doi.org/10.1159/000333562